These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7841802)

  • 1. Coexpression of cancer-associated carbohydrate antigens, Tn and sialyl Tn.
    Nakada H; Inoue M; Tanaka N; Yamashina I
    Glycoconj J; 1994 Jun; 11(3):262-5. PubMed ID: 7841802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated glycoproteins defined by a monoclonal antibody, MLS 128, recognizing the Tn antigen.
    Nakada H; Inoue M; Numata Y; Tanaka N; Funakoshi I; Fukui S; Yamashina I
    Biochem Biophys Res Commun; 1992 Aug; 187(1):217-24. PubMed ID: 1520302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of an anti-Siaalpha2-6GalNAcalpha-Ser/Thr (sialyl Tn) monoclonal antibody (MLS 132).
    Tanaka N; Nakada H; Inoue M; Yamashina I
    Eur J Biochem; 1999 Jul; 263(1):27-32. PubMed ID: 10429183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
    King MJ; Chan A; Roe R; Warren BF; Dell A; Morris HR; Bartolo DC; Durdey P; Corfield AP
    Glycobiology; 1994 Jun; 4(3):267-79. PubMed ID: 7949653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the Tn antigen on T-lymphoid cell line Jurkat.
    Nakada H; Inoue M; Tanaka N; Numata Y; Kitagawa H; Fukui S; Yamashina I
    Biochem Biophys Res Commun; 1991 Sep; 179(2):762-7. PubMed ID: 1716888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
    Freire T; Casaravilla C; Carmona C; Osinaga E
    Int J Parasitol; 2003 Jan; 33(1):47-56. PubMed ID: 12547345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
    Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
    Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
    Huang J; Byrd JC; Yoon WH; Kim YS
    Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoenzymatic synthesis of sialylated glycopeptides derived from mucins and T-cell stimulating peptides.
    George SK; Schwientek T; Holm B; Reis CA; Clausen H; Kihlberg J
    J Am Chem Soc; 2001 Nov; 123(45):11117-25. PubMed ID: 11697954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-glycosylation in Echinococcus granulosus: identification and characterization of the carcinoma-associated Tn antigen.
    Alvarez Errico D; Medeiros A; Míguez M; Casaravilla C; Malgor R; Carmona C; Nieto A; Osinaga E
    Exp Parasitol; 2001 Jun; 98(2):100-9. PubMed ID: 11465993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of hamster submaxillary sialyl-Tn and Tn glycoproteins with Gal, GalNAc and GlcNAc specific lectins.
    Wu AM; Shen F; Herp A; Wu JH
    Mol Immunol; 1994 Apr; 31(6):485-90. PubMed ID: 8183285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.
    Thurnher M; Clausen H; Fierz W; Lanzavecchia A; Berger EG
    Eur J Immunol; 1992 Jul; 22(7):1835-42. PubMed ID: 1378020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128).
    Nakada H; Inoue M; Numata Y; Tanaka N; Funakoshi I; Fukui S; Mellors A; Yamashina I
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2495-9. PubMed ID: 7681597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies recognising sialyl-Tn: production and application to immunochemistry.
    Devine PL; Birrell GW; Quin RJ; Shield PW
    Dis Markers; 1995 Aug; 12(3):175-86. PubMed ID: 8590544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic basis for sialyl-Tn expression in human colon cancer cells.
    Brockhausen I; Yang J; Dickinson N; Ogata S; Itzkowitz SH
    Glycoconj J; 1998 Jun; 15(6):595-603. PubMed ID: 9881766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.
    Osinaga E; Pancino G; Porchet N; Berois N; De Cremoux P; Mistro D; Aubert JP; Calvo F; Roseto A
    Breast Cancer Res Treat; 1994; 32(2):139-52. PubMed ID: 7532464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in sialyl-Tn antigen expression between keratoacanthomas and cutaneous squamous cell carcinomas.
    Jensen P; Clausen OP; Bryne M
    J Cutan Pathol; 1999 Apr; 26(4):183-9. PubMed ID: 10335895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of soluble Tn glycoproteins from malignant effusions of patients with carcinomas.
    Freire T; Medeiros A; Reis CA; Real FX; Osinaga E
    Oncol Rep; 2003; 10(5):1577-85. PubMed ID: 12883744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tn antigen is expressed on leukosialin from T-lymphoid cells.
    Inoue M; Nakada H; Tanaka N; Yamashina I
    Cancer Res; 1994 Jan; 54(1):85-8. PubMed ID: 8261467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An O-acetylated sialyl-Tn is involved in ovarian cancer-associated antigenicity.
    Toba S; Tenno M; Kurosaka A
    Biochem Biophys Res Commun; 2000 May; 271(2):281-6. PubMed ID: 10799288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.